Purchases and Sales Made in Q4 2023 in Sab Biotherapeutics, Inc. (SABS)
This table provides information about the institutional ownership of Sab Biotherapeutics, Inc. (SABS) during Q4 2023. The information is specifically focused on institutions that hold shares of SAB Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
9.18MNew |
$5.69M - $9.18M
|
9.18M
$28.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Bvf Inc
San Francisco, CA |
BUY
|
- |
9.18MNew |
$5.69M - $9.18M
|
9.18M
$28.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Sessa Capital Im, L.P.
New York, NY |
BUY
|
- |
4.58MNew |
$2.84M - $4.58M
|
4.58M
$14.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Pathstone Holdings, LLC
Englewood, NJ |
BUY
|
- |
507KNew |
$314K - $507K
|
507K
$1.57M
|
|
|
Feb 14, 2024
Q4 2023
|
Kestra Advisory Services, LLC
|
BUY
|
- |
67K+ 319.05% |
$41.5K - $67K
|
88K
$273K
|
|
|
Feb 05, 2024
Q4 2023
|
Silver Oak Securities, Inc
Jackson, TN |
BUY
|
- |
51.9KNew |
$32.2K - $51.9K
|
51.9K
$161K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
19.2K+ 1.96% |
$11.9K - $19.2K
|
996K
$3.09M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
16.7KNew |
$10.4K - $16.7K
|
16.7K
$51.8K
|
|
|
Feb 06, 2024
Q4 2023
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
12.8KNew |
$7.95K - $12.8K
|
12.8K
$39.8K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
11.5KNew |
$7.13K - $11.5K
|
11.5K
$35.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Spectrum Wealth Counsel, LLC
Indianapolis, IN |
BUY
|
- |
5.03KNew |
$3.12K - $5.03K
|
5.03K
$15.6K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
5K+ 8.61% |
$3.1K - $5K
|
63.1K
$196K
|
|
|
Feb 14, 2024
Q4 2023
|
Lm Advisors LLC
San Diego, CA |
BUY
|
- |
3.62KNew |
$2.24K - $3.62K
|
3.62K
$11.2K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
500New |
$310 - $500
|
500
$1.55K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
295+ 1.97% |
$183 - $295
|
15.2K
$47.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
54New |
$33.5 - $54
|
54
$167
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
26+ 9.7% |
$16.1 - $26
|
294
$911
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
24+ 2.59% |
$14.9 - $24
|
951
$2.95K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-300- 0.64% |
$186 - $300
|
46.4K
$144K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.9K- 25.31% |
$2.42K - $3.9K
|
11.5K
$35.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-5.03K- 98.67% |
$3.12K - $5.03K
|
68
$211
|